Article
Predicting BRCA mutation and stratifying targeted therapy response using multimodal learning: a multicenter study.
Annals of medicine - 1 Dec 2024
Li Yi, Xiong Xiaomin, Liu Xiaohua, Xu Mengke, Yang Boping, Li Xiaoju, Li Yu, Lin Bo, Xu Bo
Abstract excerpt
BACKGROUND: The status of BRCA1/2 genes plays a crucial role in the treatment decision-making process for multiple cancer types. However, due to high costs and limited resources, a demand for BRCA1/2 genetic testing among patients is currently unmet. Notably, not all patients with BRCA1/2 mutations achieve favorable outcomes with poly (ADP-ribose) polymerase inhibitors (PARPi), indicating the necessity for risk...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
